<p>梅薩實驗室（NASDAQ:MLAB - 獲取免費報告）在週三發佈的一份報告中被 StockNews.com 的股票研究分析師從 “買入” 評級下調至 “持有” 評級。</p>
<p>獲取 <strong>梅薩實驗室</strong> 的提醒：</p>
<p>其他幾家券商也對 MLAB 發表了評論。富國銀行在 8 月 27 日的報告中開始覆蓋梅薩實驗室的股票。他們給予該公司的評級為 “減持”，目標價為 120.00 美元。Evercore ISI 在 10 月 1 日的研究報告中將梅薩實驗室的目標價從 120.00 美元上調至 160.00 美元，並給予該公司 “跑贏大盤” 的評級。</p>
<p><strong>獲取我們對梅薩實驗室的最新分析</strong></p>
<h2>梅薩實驗室股票下跌 5.5%</h2>
<p>週三，NASDAQ MLAB 的股票開盤價為 112.40 美元。該公司的 50 日簡單移動平均線為 124.09 美元，200 日簡單移動平均線為 115.00 美元。梅薩實驗室的 12 個月低點為 82.86 美元，12 個月高點為 141.17 美元。該公司的流動比率為 1.94，速動比率為 1.37，債務與股本比率為 1.38。該公司的市值為 6.0808 億美元，市盈率為-2.47，貝塔值為 0.87。</p>
<h2>梅薩實驗室的內部買賣</h2>
<p>在其他新聞中，首席執行官 Gary M. Owens 在 10 月 28 日星期一出售了 2,518 股公司的股票，交易價格為 113.62 美元，總價值為 286,095.16 美元。出售後，首席執行官現在直接擁有 45,888 股公司的股票，價值為 5,213,794.56 美元。此次交易使其持股量減少了 0.00%。該交易在向 SEC 提交的文件中披露，文件可通過 SEC 網站獲取。在其他新聞中，高級副總裁 Brian David Archbold 在 9 月 13 日星期五出售了 1,499 股梅薩實驗室的股票，交易價格為 125.00 美元，總價值為 187,375.00 美元。該交易在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。此外，首席執行官 Gary M. Owens 在 10 月 28 日星期一再次出售了 2,518 股股票，交易價格為 113.62 美元，總交易額為 286,095.16 美元。出售後，首席執行官現在直接擁有 45,888 股公司的股票，價值為 5,213,794.56 美元。此次交易使其持股量減少了 0.00%。該出售的披露信息可以在這裏找到。內部人士持有公司 4.40% 的股票。</p>
<h2>機構資金流入和流出</h2>
<p>對沖基金和其他機構投資者最近對該公司的持倉進行了調整。Meros Investment Management LP 在第二季度購買了梅薩實驗室的新頭寸，價值約為 2,456,000 美元。Keeley Teton Advisors LLC 在第一季度購買了梅薩實驗室的新股份，價值為 2,606,000 美元。Charles Schwab Investment Management Inc.在第三季度將其在梅薩實驗室的股份提高了 38.6%。Charles Schwab Investment Management Inc.現在擁有 62,609 股醫療儀器供應商的股票，價值為 8,130,000 美元，此前在上個季度購買了額外的 17,450 股。Eagle Asset Management Inc.在第三季度將其在梅薩實驗室的持股提高了 10.9%。Eagle Asset Management Inc.現在擁有 165,955 股醫療儀器供應商的股票，價值為 19,722,000 美元，此前在上個季度購買了額外的 16,293 股。最後，Dimensional Fund Advisors LP 在第二季度將其在梅薩實驗室的持倉提高了 7.1%。Dimensional Fund Advisors LP 現在擁有 131,891 股醫療儀器供應商的股票，價值為 11,444,000 美元，此前在上個季度購買了額外的 8,722 股。機構投資者持有公司 90.60% 的股票。</p>
<h2>梅薩實驗室公司簡介</h2>
<p>（獲取免費報告）</p>
<p>梅薩實驗室公司在北美、歐洲、亞太地區及國際上開發、設計、製造、銷售和服務生命科學工具及質量控制產品和服務。滅菌和消毒控制部門提供生物、化學和清潔指示劑，用於評估製藥、醫療器械和醫療行業中滅菌、消毒和清潔過程的有效性。</p>
<h2>特色文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過梅薩實驗室</li>
<li>現在值得購買的三隻最佳金融科技股票</li>
<li>家得寶股票：2024 年目標 12%，2025 年再增 25%</li>
<li>寶潔公司 NYSE: PG 在不穩定的指導後回落</li>
<li>特斯拉的估值是泡沫還是有實際增長支撐？</li>
<li>能源和石油股票解析</li>
<li>上週運輸股票領跑：它們能否繼續上漲？</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<p>→ 現在市場上最值得關注的 “沉睡巨人” 加密貨幣（來自 Crypto 101 Media）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMzNQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMzNQ"/></p>
<h2>你現在應該投資 1,000 美元在梅薩實驗室嗎？</h2>
<p>在考慮梅薩實驗室之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而梅薩實驗室並不在名單上。</p>
<p>雖然梅薩實驗室目前在分析師中獲得了 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

MLAB

<p>StockNews.com 已將 Mesa Laboratories（NASDAQ:MLAB）的評級從 “買入” 下調至 “持有”。該股票開盤價為 40.40 美元，下跌 5.5%。其他券商也發表了評論，富國銀行給予 “減持” 評級，而 Evercore ISI 則上調了其目標價。內部交易方面，首席執行官 Gary M. Owens 出售了部分股份，減少了其持股比例。機構投資者持有該公司 90.60% 的股份，近期有多個基金進行了購買。Mesa Laboratories 專注於生命科學工具和質量控制產品</p>

<p>Mesa Laboratories (NASDAQ:MLAB - Get Free Report) was downgraded by equities research analysts at StockNews.com from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report released on Wednesday.</p>
<div class="lb-trans"><p>梅薩實驗室（NASDAQ:MLAB - 獲取免費報告）在週三發佈的一份報告中被 StockNews.com 的股票研究分析師從 “買入” 評級下調至 “持有” 評級。</p>
</div><p>Get <strong>Mesa Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>梅薩實驗室</strong> 的提醒：</p>
</div><p>Several other brokerages have also commented on MLAB. Wells Fargo &amp; Company started coverage on shares of Mesa Laboratories in a report on Tuesday, August 27th. They issued an &#34;underweight&#34; rating and a $120.00 price objective for the company. Evercore ISI lifted their price target on Mesa Laboratories from $120.00 to $160.00 and gave the company an &#34;outperform&#34; rating in a research report on Tuesday, October 1st.</p>
<div class="lb-trans"><p>其他幾家券商也對 MLAB 發表了評論。富國銀行在 8 月 27 日的報告中開始覆蓋梅薩實驗室的股票。他們給予該公司的評級為 “減持”，目標價為 120.00 美元。Evercore ISI 在 10 月 1 日的研究報告中將梅薩實驗室的目標價從 120.00 美元上調至 160.00 美元，並給予該公司 “跑贏大盤” 的評級。</p>
</div><p><strong>Get Our Latest Analysis on Mesa Laboratories</strong></p>
<div class="lb-trans"><p><strong>獲取我們對梅薩實驗室的最新分析</strong></p>
</div><h2>Mesa Laboratories Stock Down 5.5 %</h2>
<div class="lb-trans"><h2>梅薩實驗室股票下跌 5.5%</h2>
</div><p>Shares of NASDAQ MLAB opened at $112.40 on Wednesday. The firm has a fifty day simple moving average of $124.09 and a two-hundred day simple moving average of $115.00. Mesa Laboratories has a 12 month low of $82.86 and a 12 month high of $141.17. The company has a current ratio of 1.94, a quick ratio of 1.37 and a debt-to-equity ratio of 1.38. The firm has a market capitalization of $608.08 million, a PE ratio of -2.47 and a beta of 0.87.</p>
<div class="lb-trans"><p>週三，NASDAQ MLAB 的股票開盤價為 112.40 美元。該公司的 50 日簡單移動平均線為 124.09 美元，200 日簡單移動平均線為 115.00 美元。梅薩實驗室的 12 個月低點為 82.86 美元，12 個月高點為 141.17 美元。該公司的流動比率為 1.94，速動比率為 1.37，債務與股本比率為 1.38。該公司的市值為 6.0808 億美元，市盈率為-2.47，貝塔值為 0.87。</p>
</div><h2>Insider Buying and Selling at Mesa Laboratories</h2>
<div class="lb-trans"><h2>梅薩實驗室的內部買賣</h2>
</div><p>In other news, CEO Gary M. Owens sold 2,518 shares of the business's stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $113.62, for a total value of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares of the company's stock, valued at $5,213,794.56. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, SVP Brian David Archbold sold 1,499 shares of Mesa Laboratories stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $125.00, for a total value of $187,375.00. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, CEO Gary M. Owens sold 2,518 shares of the stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $113.62, for a total transaction of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares in the company, valued at $5,213,794.56. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.40% of the company's stock.</p>
<div class="lb-trans"><p>在其他新聞中，首席執行官 Gary M. Owens 在 10 月 28 日星期一出售了 2,518 股公司的股票，交易價格為 113.62 美元，總價值為 286,095.16 美元。出售後，首席執行官現在直接擁有 45,888 股公司的股票，價值為 5,213,794.56 美元。此次交易使其持股量減少了 0.00%。該交易在向 SEC 提交的文件中披露，文件可通過 SEC 網站獲取。在其他新聞中，高級副總裁 Brian David Archbold 在 9 月 13 日星期五出售了 1,499 股梅薩實驗室的股票，交易價格為 125.00 美元，總價值為 187,375.00 美元。該交易在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。此外，首席執行官 Gary M. Owens 在 10 月 28 日星期一再次出售了 2,518 股股票，交易價格為 113.62 美元，總交易額為 286,095.16 美元。出售後，首席執行官現在直接擁有 45,888 股公司的股票，價值為 5,213,794.56 美元。此次交易使其持股量減少了 0.00%。該出售的披露信息可以在這裏找到。內部人士持有公司 4.40% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the company. Meros Investment Management LP purchased a new position in Mesa Laboratories in the 2nd quarter worth approximately $2,456,000. Keeley Teton Advisors LLC bought a new stake in shares of Mesa Laboratories in the 1st quarter worth $2,606,000. Charles Schwab Investment Management Inc. raised its stake in shares of Mesa Laboratories by 38.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 62,609 shares of the medical instruments supplier's stock worth $8,130,000 after purchasing an additional 17,450 shares during the last quarter. Eagle Asset Management Inc. lifted its holdings in shares of Mesa Laboratories by 10.9% during the third quarter. Eagle Asset Management Inc. now owns 165,955 shares of the medical instruments supplier's stock valued at $19,722,000 after purchasing an additional 16,293 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Mesa Laboratories by 7.1% during the second quarter. Dimensional Fund Advisors LP now owns 131,891 shares of the medical instruments supplier's stock valued at $11,444,000 after buying an additional 8,722 shares during the last quarter. Institutional investors own 90.60% of the company's stock.</p>
<div class="lb-trans"><p>對沖基金和其他機構投資者最近對該公司的持倉進行了調整。Meros Investment Management LP 在第二季度購買了梅薩實驗室的新頭寸，價值約為 2,456,000 美元。Keeley Teton Advisors LLC 在第一季度購買了梅薩實驗室的新股份，價值為 2,606,000 美元。Charles Schwab Investment Management Inc.在第三季度將其在梅薩實驗室的股份提高了 38.6%。Charles Schwab Investment Management Inc.現在擁有 62,609 股醫療儀器供應商的股票，價值為 8,130,000 美元，此前在上個季度購買了額外的 17,450 股。Eagle Asset Management Inc.在第三季度將其在梅薩實驗室的持股提高了 10.9%。Eagle Asset Management Inc.現在擁有 165,955 股醫療儀器供應商的股票，價值為 19,722,000 美元，此前在上個季度購買了額外的 16,293 股。最後，Dimensional Fund Advisors LP 在第二季度將其在梅薩實驗室的持倉提高了 7.1%。Dimensional Fund Advisors LP 現在擁有 131,891 股醫療儀器供應商的股票，價值為 11,444,000 美元，此前在上個季度購買了額外的 8,722 股。機構投資者持有公司 90.60% 的股票。</p>
</div><h2>Mesa Laboratories Company Profile</h2>
<div class="lb-trans"><h2>梅薩實驗室公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.</p>
<div class="lb-trans"><p>梅薩實驗室公司在北美、歐洲、亞太地區及國際上開發、設計、製造、銷售和服務生命科學工具及質量控制產品和服務。滅菌和消毒控制部門提供生物、化學和清潔指示劑，用於評估製藥、醫療器械和醫療行業中滅菌、消毒和清潔過程的有效性。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Mesa Laboratories</li>
<li>The 3 Best Fintech Stocks to Buy Now</li>
<li>Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025</li>
<li>Procter &amp; Gamble NYSE: PG Pulls Back After Shaky Guidance</li>
<li>Is Tesla's Valuation a Bubble or Backed by Real Growth?</li>
<li>Energy and Oil Stocks Explained</li>
<li>Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過梅薩實驗室</li>
<li>現在值得購買的三隻最佳金融科技股票</li>
<li>家得寶股票：2024 年目標 12%，2025 年再增 25%</li>
<li>寶潔公司 NYSE: PG 在不穩定的指導後回落</li>
<li>特斯拉的估值是泡沫還是有實際增長支撐？</li>
<li>能源和石油股票解析</li>
<li>上週運輸股票領跑：它們能否繼續上漲？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><p>→ Top &#34;Sleeping Giant&#34; Crypto In The Market Now (From Crypto 101 Media)(Ad)</p>
<div class="lb-trans"><p>→ 現在市場上最值得關注的 “沉睡巨人” 加密貨幣（來自 Crypto 101 Media）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMzNQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10335&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Mesa Laboratories right now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在梅薩實驗室嗎？</h2>
</div><p>Before you consider Mesa Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮梅薩實驗室之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而梅薩實驗室並不在名單上。</p>
</div><p>While Mesa Laboratories currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然梅薩實驗室目前在分析師中獲得了 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Mesa Laboratories（納斯達克股票代碼：MLAB）的股票評級被 StockNews.com 下調